Avandia: GlaxoSmithKline Accused Of Covering Up Heart Risks Of Diabetes Pill (VIDEO)

07/13/2010 12:37 pm ET | Updated May 25, 2011

GlaxoSmithKline hid the fact that their drug, Avandia, caused heart risks for 11 years, according to the New York Times.

Avandia was once a huge seller for GSK, but its potential ties to heart attacks caused the FDA to do a 700-page review of the drug ahead of a meeting that will decide whether or not it will continue to be sold.

The company reportedly knew the risks of the drug as early as 1999, but declined to make their information public for fear of losing millions.


Suggest a correction